To study the disease mechanisms underlining PARK2-mediated PD, we compared healthy human iPSCs and isogenic iPSCs where the PARK2 gene was deleted using zinc finger nuclease gene editing [24]. This evidence concerns the gene PRKN and Parkinson disease.